Specifically, DCs function in immunotherapy by presenting tumor antigens to naïve T cells, and exosomes secreted from DCs contain CD80 and CD86 that are required for naïve CD4+ T-cell activation (26). The gene discussed is CD86; the disease is neoplasm.